InsidersTradesSigma
Track the 美诺华 stock price and the full insider trade history of the company, a publicly traded company based in China. Shares trade on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 美诺华 has recorded 2 insider filings. Market capitalisation: €8.2bn. The latest transaction was disclosed on 27 May 2021 (Purchase). Among the most active insiders: 许健配偶. All data is free.
2
Insider Decl.
n/a
Thresholds
€37,713
1 ops.
Buy Volume
€36,950
1 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 20,768 of 28,752 companies
36.8
score / 100
Value31
Quality43
FCF yld0.6%
Earn yld1.3%
EV/EBITDA31.4x
ROE4.8%
Gross mgn35%
Net mgn6.8%
Debt/EBITDA4.9x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 27 May 2021
About 美诺华
美诺华 is a company operating in the healthcare and pharmaceutical sector, listed on the XSHG market. It focuses on the development and commercialization of innovative pharmaceutical products.